113 related articles for article (PubMed ID: 19786846)
41. HIV-1 Nef in macrophage-mediated disease pathogenesis.
Lamers SL; Fogel GB; Singer EJ; Salemi M; Nolan DJ; Huysentruyt LC; McGrath MS
Int Rev Immunol; 2012 Dec; 31(6):432-50. PubMed ID: 23215766
[TBL] [Abstract][Full Text] [Related]
42. T cell signaling mechanisms that regulate HIV-1 infection.
Unutmaz D
Immunol Res; 2001; 23(2-3):167-77. PubMed ID: 11444382
[TBL] [Abstract][Full Text] [Related]
43. HIV-1-Mediated BAFF Secretion in Macrophages Does Not Require Endosomal TLRs, Type-I IFN, and Nef, but Depends on the Cellular Phenotype Status.
Gomez AM; Ouellet M; Deshiere A; Breton Y; Tremblay MJ
J Immunol; 2016 May; 196(9):3806-17. PubMed ID: 27022194
[TBL] [Abstract][Full Text] [Related]
44. Adult AIDS-like disease in a novel inducible human immunodeficiency virus type 1 Nef transgenic mouse model: CD4+ T-cell activation is Nef dependent and can occur in the absence of lymphophenia.
Rahim MM; Chrobak P; Hu C; Hanna Z; Jolicoeur P
J Virol; 2009 Nov; 83(22):11830-46. PubMed ID: 19740990
[TBL] [Abstract][Full Text] [Related]
45. CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease.
Weng X; Priceputu E; Chrobak P; Poudrier J; Kay DG; Hanna Z; Mak TW; Jolicoeur P
J Virol; 2004 May; 78(10):5244-57. PubMed ID: 15113906
[TBL] [Abstract][Full Text] [Related]
46. Extracellular Nef of HIV-1 can target CD4 memory T population.
Otake K; Ohta M; Minowada J; Hatama S; Takahashi E; Ikemoto A; Okuyama H; Fujii Y
AIDS; 2000 Jul; 14(11):1662-4. PubMed ID: 10983657
[No Abstract] [Full Text] [Related]
47. Strong ifitm1 Expression in CD4 T Cells in HIV Controllers Is Correlated With Immune Activation.
Canoui E; Noël N; Lécuroux C; Boufassa F; Sáez-Cirión A; Bourgeois C; Lambotte O;
J Acquir Immune Defic Syndr; 2017 Feb; 74(2):e56-e59. PubMed ID: 27552157
[No Abstract] [Full Text] [Related]
48. Replication competent HIV-guided CRISPR screen identifies antiviral factors including targets of the accessory protein Nef.
Prelli Bozzo C; Laliberté A; De Luna A; Pastorio C; Regensburger K; Krebs S; Graf A; Blum H; Volcic M; Sparrer KMJ; Kirchhoff F
Nat Commun; 2024 May; 15(1):3813. PubMed ID: 38714682
[TBL] [Abstract][Full Text] [Related]
49. Unraveling the function of HIV type 1 Nef.
Geleziunas R; Miller MD; Greene WC
AIDS Res Hum Retroviruses; 1996 Nov; 12(17):1579-82. PubMed ID: 8947291
[No Abstract] [Full Text] [Related]
50. Studying the Immune Synapse in HIV-1 Infection.
Del Río-Iñiguez I; Bouchet J; Alcover A
Methods Mol Biol; 2017; 1584():545-557. PubMed ID: 28255725
[TBL] [Abstract][Full Text] [Related]
51. A model of primary HIV-1 infection.
Murray JM; Kaufmann G; Kelleher AD; Cooper DA
Math Biosci; 1998 Dec; 154(2):57-85. PubMed ID: 9949648
[TBL] [Abstract][Full Text] [Related]
52. [Viral reservoir in HIV-2 infection: a model for attenuated retroviral infection].
Samri A; Charpentier C; Cheynier R; Matheron S; Brun-Vézinet F; Autran B;
Med Sci (Paris); 2020 Apr; 36(4):336-339. PubMed ID: 32356709
[No Abstract] [Full Text] [Related]
53. Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection.
Perisé-Barrios AJ; Jiménez JL; Domínguez-Soto A; de la Mata FJ; Corbí AL; Gomez R; Muñoz-Fernandez MÁ
J Control Release; 2014 Jun; 184():51-7. PubMed ID: 24721235
[TBL] [Abstract][Full Text] [Related]
54. HIV-Nef and ADAM17-Containing Plasma Extracellular Vesicles Induce and Correlate with Immune Pathogenesis in Chronic HIV Infection.
Lee JH; Schierer S; Blume K; Dindorf J; Wittki S; Xiang W; Ostalecki C; Koliha N; Wild S; Schuler G; Fackler OT; Saksela K; Harrer T; Baur AS
EBioMedicine; 2016 Apr; 6():103-113. PubMed ID: 27211553
[TBL] [Abstract][Full Text] [Related]
55. Alterations of the B-cell response by HIV-1 replication.
Shen X; Tomaras GD
Curr HIV/AIDS Rep; 2011 Mar; 8(1):23-30. PubMed ID: 21161615
[TBL] [Abstract][Full Text] [Related]
56. Loss of HIV-1-specific T cell proliferation in chronic HIV-1 infection: cause or consequence of viral replication?
Lichterfeld M; Pantaleo G; Altfeld M
AIDS; 2005 Jul; 19(11):1225-7. PubMed ID: 15990577
[No Abstract] [Full Text] [Related]
57. The CD4(+) T cell response to HIV-1.
Picker LJ; Maino VC
Curr Opin Immunol; 2000 Aug; 12(4):381-6. PubMed ID: 10899031
[TBL] [Abstract][Full Text] [Related]
58. HIV Nef- and Notch1-dependent Endocytosis of ADAM17 Induces Vesicular TNF Secretion in Chronic HIV Infection.
Ostalecki C; Wittki S; Lee JH; Geist MM; Tibroni N; Harrer T; Schuler G; Fackler OT; Baur AS
EBioMedicine; 2016 Nov; 13():294-304. PubMed ID: 27773542
[TBL] [Abstract][Full Text] [Related]
59. The moving target: mechanisms of HIV persistence during primary infection.
Soudeyns H; Pantaleo G
Immunol Today; 1999 Oct; 20(10):446-50. PubMed ID: 10500291
[TBL] [Abstract][Full Text] [Related]
60. Cutting Edge: Regulation of Exosome Secretion by the Integral MAL Protein in T Cells.
Ventimiglia LN; Fernández-Martín L; Martínez-Alonso E; Antón OM; Guerra M; Martínez-Menárguez JA; Andrés G; Alonso MA
J Immunol; 2015 Aug; 195(3):810-4. PubMed ID: 26109641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
